Investment ThemesDetailed Quotes
Weight Loss Drugs
Watchlist
GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
- 1552.310
- -71.069-4.38%
Close Nov 15 16:00 ET
1599.544High1547.450Low
1599.544Open1623.379Pre Close166.39MVolume--Rise56.91P/E (Static)11.62BTurnover--Flatline1.58%Turnover Ratio1.46TMarket Cap7Fall1.33TFloat Cap
Constituent Stocks: 7Top Rising: NVO-3.40%
LLY closed at 746.20 just below 746.51, the support line. It is such a small difference that it could be just AI cleaning up the stop-loss. We need follow through next week for confirmation. Double top, broke support 2 out 3 items checked off already for a breakdown.
Watch for 716, below that there would be no question that it is a breakdown. I wouldn't be surprised that Monday morning we will be gapping down.
1. DOGE - will review policies of govt regulations on procurement esp big ticket items i.e. healthcare (drug), insurance, defence etc
2. Dept of Healthcare - will endorse DOGE recommendation and even tighten further to save billions on govt drug spending!
3. Stiff competitions from many small startups (leveraging AI on new drug diac...
bottom or not?
more selling
No comment yet